FDA Inspection 915034 — Supernus Pharmaceuticals, Inc.
The FDA completed an inspection of Supernus Pharmaceuticals, Inc. on February 23, 2015 in Rockville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 23, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rockville, MD (United States)